- Asensus Surgical press release ( NYSE: ASXC ): Q2 Non-GAAP EPS of -$0.07.
- Revenue of $1M (-9.1% Y/Y).
- Shares +4.8% .
- Total operating expenses were $18.2 million, as compared to $14.8 million, in the three months ended June 30, 2021.
- For the full year 2022, the Company now expects to initiate 8 - 10 new Senhance Surgical Systems.
- ompany had cash, cash equivalents, short-term and long-term investments, excluding restricted cash of approximately $103.8 million as of June 30, 2022.
For further details see:
Asensus Surgical non-GAAP EPS of -$0.07, revenue of $1M